Alere Inc (ALR)

50.99
0.00 (0.00)
NYSE : Health Care
Prev Close 50.99
Open 50.99
Day Low/High 50.98 / 51.00
52 Wk Low/High 34.41 / 51.00
Volume 1.22M
Avg Volume 1.88M
Exchange NYSE
Shares Outstanding 87.58M
Market Cap 4.47B
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
Alere Inc Stock Downgraded (ALR)

Alere Inc Stock Downgraded (ALR)

Alere Inc (NYSE:ALR) has been downgraded by TheStreet Ratings from from a hold to sell.

Alere Rises On Unusually High Volume (ALR)

Alere Rises On Unusually High Volume (ALR)

Alere Inc (NYSE:ALR) is trading at unusually high volume Monday with 3.7 million shares changing hands. It is currently at four times its average daily volume and trading up 53 cents (+2.2%).

VitaPath Genetics And Alere Announce Strategic Partnership For The Development Of Molecular Diagnostics To Prevent Birth Defects

VitaPath Genetics And Alere Announce Strategic Partnership For The Development Of Molecular Diagnostics To Prevent Birth Defects

VitaPath Genetics and Alere (NYSE: ALR) announced today that Alere has licensed worldwide marketing rights to VitaPath’s spina bifida risk assessment assay, which is expected to be commercially launched in 2012.

Alere Stock Hits New 52-Week Low (ALR)

Alere Stock Hits New 52-Week Low (ALR)

Alere (NYSE:ALR) hit a new 52-week low Friday as it is currently trading at $25.85, below its previous 52-week low of $26.57 with 75,695 shares traded as of 10:06 a.m. ET. Average volume has been 719,100 shares over the past 30 days.

Boeing, Teva Pharma: New Targets, Estimates

Boeing, Teva Pharma: New Targets, Estimates

Boeing estimates, target raised at Goldman. Teva Pharmaceuticals estimates raised at UBS.

Alere's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Alere's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Alere's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Alere Stock Falls On Unusually High Volume (ALR)

Alere Stock Falls On Unusually High Volume (ALR)

Alere (NYSE:ALR) is trading at unusually high volume Wednesday with 2.4 million shares changing hands. It is currently at four times its average daily volume and trading down $3.81 (-11.2%).

Alere Stock Falls On Unusually High Volume (ALR)

Alere Stock Falls On Unusually High Volume (ALR)

Alere (NYSE:ALR) is trading at unusually high volume Friday with 2.1 million shares changing hands. It is currently at four times its average daily volume and trading down $1.64 (-4.5%).

Alere Stock Hits New 52-Week High (ALR)

Alere Stock Hits New 52-Week High (ALR)

Alere (NYSE:ALR) hit a new 52-week high Thursday as it is currently trading at $40.65, above its previous 52-week high of $40.55 with 157,855 shares traded as of 11:37 a.m. ET. Average volume has been 527,400 shares over the past 30 days.

Alere Stock Falls On Unusually High Volume (ALR)

Alere Stock Falls On Unusually High Volume (ALR)

Alere (NYSE:ALR) is trading at unusually high volume Wednesday with 1.8 million shares changing hands. It is currently at 4.1 times its average daily volume and trading down $2.13 (-5.5%).

Biotech Stock Mailbag: Star Scientific

Biotech Stock Mailbag: Star Scientific

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

3 Short-Squeeze Opportunities for 2011

3 Short-Squeeze Opportunities for 2011

These heavily shorted stock could get squeezed higher in 2011.